CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77.3% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 May 12, 14:30

Vir Biotechnology (VIR) Maintains 'Buy' Rating as Price Target Adjusted | VIR Stock News

Vir Biotechnology Inc
Webhose 2025 May 11, 13:34

Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Trimming Their Forecasts

Vir Biotechnology Inc
Webhose 2025 May 11, 10:38

Vir Biotechnology (NASDAQ:VIR) Trading Down 5.5% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 May 11, 07:51

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Purchased by Dimensional Fund Advisors LP

Vir Biotechnology Inc
Webhose 2025 May 09, 12:15

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2025 Earnings Call Transcript

Vir Biotechnology Inc
Webhose 2025 May 09, 10:42

Vir Biotechnology (VIR) Unveils Promising Hepatitis B Treatment Data | VIR Stock News

Vir Biotechnology Inc
Webhose 2025 May 09, 10:00

Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study | Morningstar

Vir Biotechnology Inc
Webhose 2025 May 08, 07:31

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

Vir Biotechnology Inc
Webhose 2025 May 08, 05:13

Q1 2025 Vir Biotechnology Inc Earnings Call Transcript

Vir Biotechnology Inc
Webhose 2025 May 05, 07:27

Barclays PLC Has $1.62 Million Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 04, 11:44

1,084,539 Shares in Vir Biotechnology, Inc. (NASDAQ:VIR) Bought by Baker BROS. Advisors LP

Vir Biotechnology Inc
Webhose 2025 May 04, 10:37

Quarry LP Sells 11,000 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 May 03, 09:04

BlackRock, Inc. Reduces Stake in Vir Biotechnology Inc.

Vir Biotechnology Inc
Webhose 2025 May 01, 00:00

VIR Q1 2025 Earnings Report on 5/1/2025

Vir Biotechnology Inc
Webhose 2025 Apr 27, 09:32

Syon Capital LLC Makes New $77,000 Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 26, 07:45

Vir Biotechnology (VIR) to Release Earnings on Thursday

Vir Biotechnology Inc
Webhose 2025 Apr 25, 10:23

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Analysts

Vir Biotechnology Inc
Webhose 2025 Apr 23, 17:58

Vir Biotechnology (NASDAQ:VIR) Shares Up 5.5% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 Apr 20, 09:26

Vir Biotechnology, Inc. (NASDAQ:VIR) Short Interest Up 28.3% in March

Vir Biotechnology Inc
Webhose 2025 Apr 20, 08:36

Walleye Capital LLC Increases Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 20, 07:52

Renaissance Technologies LLC Buys 55,300 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc

VirBiotechnology news

2025 Business Trend and Market
Christine Voong 2025 Feb 13, 21:36

Business Trends 2025: Key Insights Shaping the Future of Global Markets

Latest news

Show more
Frances Wang 2025 May 13, 16:00

XRP News Today: XRP Rises on Increased Bank Demand in the US

Cryptocurrencies
Tommy Yap 2025 May 13, 16:00

Morning Note: Tencent's Report in Focus; Gold Affected by Trade Optimism; Oil Stable

Morning Note China Commodities
Frances Wang 2025 May 12, 16:00

ADA crypto price forecast: What factors influence the price of Cardano?

Cryptocurrencies
Tommy Yap 2025 May 12, 16:00

Morning Note: Tariff Rollback Sparks Stock Rally; US CPI Watch; Bailey's Speech

Morning Note Equities
Tommy Yap 2025 May 12, 04:00

Morning Note: US Surplus Expected; Denmark Inflation; UK Retail Sales Forecast

Morning Note EUR
Frances Wang 2025 May 11, 16:00

How the US-China Trade War Influenced Global Commodity Markets?

Commodities
Tommy Yap 2025 May 09, 21:00

Week Ahead: U.S. Inflation Data in Spotlight

Forex Indices
Frances Wang 2025 May 08, 16:00

What Is Happening to the Bond Market: Bond Market Outlook 2025

Bonds

Info

Spread

0.03

Spread (%)

0.6787 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

731739200

Shares Outstanding

138064000

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-4.23

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 May 13, 16:00

MT4 brokers for forex: Pepperstone, FxPro, Capital.com, markets.com

Forex
Frances Wang 2025 May 13, 16:00

Canadian Dollar Forecast: USD/CAD Softens on China/US Tariff Deal

Frances Wang 2025 May 12, 16:00

Forex trading learning sites: Babypips, forex.com, FxPro, Pepperstone

Trustpilot